01.07.2014 Views

The ABCs of systemic healthcare reform - Cerner Corporation

The ABCs of systemic healthcare reform - Cerner Corporation

The ABCs of systemic healthcare reform - Cerner Corporation

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

amounts that include the amounts attributable to both the parent and the noncontrolling interest. <strong>The</strong> Company is currently<br />

assessing the impact <strong>of</strong> adoption <strong>of</strong> SFAS 160 on its results <strong>of</strong> operations and its financial position, both <strong>of</strong> which are expected<br />

to be immaterial, and was required to adopt SFAS 160 as <strong>of</strong> the first day <strong>of</strong> the 2009 fiscal year.<br />

In March 2008, the FASB issued Statement <strong>of</strong> Accounting Standards No. 161, “Disclosures about Derivative Instruments and<br />

Hedging Activities – an amendment <strong>of</strong> FASB Statement No. 133.” SFAS 161 requires enhanced disclosures about the uses <strong>of</strong><br />

derivative instruments and hedging activities, how these activities are accounted for, and their respective impact on an entity’s<br />

financial position, financial performance, and cash flows. <strong>The</strong> Company is currently assessing the impact <strong>of</strong> adoption <strong>of</strong> SFAS<br />

161 on its results <strong>of</strong> operations and its financial position, which is expected to be immaterial, and was required to adopt SFAS<br />

161 as <strong>of</strong> the first day <strong>of</strong> the 2009 fiscal year.<br />

(2) Business Acquisitions<br />

During the three years ended January 3, 2009, the Company completed three acquisitions, which were accounted for under the<br />

purchase method <strong>of</strong> accounting. <strong>The</strong> results <strong>of</strong> each acquisition are included in the Company’s consolidated statements <strong>of</strong><br />

operations from the date <strong>of</strong> each acquisition. Below is a description <strong>of</strong> the acquisitions.<br />

On August 1, 2008, the Company completed the purchase <strong>of</strong> LingoLogix, Inc. (“LingoLogix”), for $4,000,000. LingoLogix was a<br />

provider <strong>of</strong> s<strong>of</strong>tware used for computer automated coding technology. <strong>The</strong> acquisition <strong>of</strong> LingoLogix has enhanced the<br />

Company’s revenue cycling <strong>of</strong>ferings as the solutions can be used in both inpatient and outpatient environments to improve<br />

physician workflow and drive more accurate and efficient reimbursement through automated coding. <strong>The</strong> operating results <strong>of</strong><br />

LingoLogix were combined with those <strong>of</strong> the Company subsequent to the purchase date <strong>of</strong> August 1, 2008. <strong>The</strong> allocation <strong>of</strong><br />

the purchase price to the estimated fair values <strong>of</strong> the identified tangible and intangible assets acquired and liabilities assumed<br />

resulted in goodwill <strong>of</strong> $1,253,000 and $4,053,000 in intangible assets. <strong>The</strong> intangible assets are being amortized over 5<br />

years. <strong>The</strong> goodwill was allocated to the reporting unit. Pro-forma results <strong>of</strong> operations have not been presented because the<br />

effect <strong>of</strong> this acquisition was not material to the Company.<br />

On February 22, 2007, the Company completed the purchase <strong>of</strong> assets <strong>of</strong> Etreby Computer Company, Inc. (“Etreby”), for<br />

$25,120,000, which was reduced by $1,588,000 for a working capital adjustment in the second quarter <strong>of</strong> 2007. Etreby was a<br />

s<strong>of</strong>tware provider <strong>of</strong> retail pharmacy management systems. <strong>The</strong> acquisition <strong>of</strong> Etreby’s assets has expanded the Company’s<br />

pharmacy systems portfolio. <strong>The</strong> operating results <strong>of</strong> Etreby were combined with those <strong>of</strong> the Company subsequent to the<br />

purchase date <strong>of</strong> February 22, 2007. <strong>The</strong> allocation <strong>of</strong> the purchase price to the estimated fair values <strong>of</strong> the identified tangible<br />

and intangible assets acquired and liabilities assumed resulted in goodwill <strong>of</strong> $12,676,000 and $10,181,000 in intangible<br />

assets. <strong>The</strong> intangible assets are being amortized over five years. <strong>The</strong> goodwill was allocated to the reporting unit and is<br />

expected to be deductible for tax purposes. Pro-forma results <strong>of</strong> operations have not been presented because the effect <strong>of</strong> this<br />

acquisition was not material to the Company.<br />

On July 5, 2006, the Company completed the purchase <strong>of</strong> Galt Associates, Inc., now known as <strong>Cerner</strong> Galt, Inc. (“Galt”) for<br />

$13,766,000, net <strong>of</strong> cash acquired. Galt is a provider <strong>of</strong> safety and risk management solutions for pharmaceutical, medical<br />

device and biotechnology companies. <strong>The</strong> acquisition <strong>of</strong> Galt has enhanced the Company’s LifeSciences portfolio by adding<br />

solutions and services that use medical event data to monitor and manage the safety and effectiveness <strong>of</strong> various therapies.<br />

<strong>The</strong> allocation <strong>of</strong> the purchase price to the estimated fair values <strong>of</strong> the identified tangible and intangible assets acquired and<br />

liabilities assumed, resulted in goodwill <strong>of</strong> $9,298,000 and $4,266,000 in intangible assets. <strong>The</strong> intangible assets are being<br />

amortized over periods between two and five years. <strong>The</strong> goodwill was allocated to the reporting unit.<br />

All <strong>of</strong> the goodwill for the above acquisitions has been allocated to the Company’s Domestic operating segment.<br />

69

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!